DYAI Return on Tangible Equity | DYADIC INTERNATIONAL INC

DYADIC INTERNATIONAL INC (DYAI) Return on Tangible Equity

2026-06-30: Return Tang Equity 319.27%.
2026-03-31: Return Tang Equity 1788.36%.
2025-12-31: Return Tang Equity -597.58%.
2025-09-30: Return Tang Equity -281.83%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	319.27%
2026-03-31	1788.36%
2025-12-31	-597.58%
2025-09-30	-281.83%
2025-06-30	1052.61%
2025-03-31	-630.91%
2024-12-31	-235.16%
2024-09-30	-185.52%
2024-06-30	-244.33%
2024-03-31	-173.80%
2023-12-31	-115.60%
2023-09-30	-89.78%
2023-06-30	-78.63%
2023-03-31	-75.90%
2022-12-31	-87.80%
2022-09-30	-93.58%
2022-06-30	-86.34%
2022-03-31	-74.82%
2021-12-31	-71.07%
2021-09-30	-49.39%
2021-06-30	-50.09%
2021-03-31	-40.51%
2020-12-31	-32.78%
2020-09-30	-30.35%
2020-06-30	-25.87%
2020-03-31	-24.37%
2019-12-31	-23.16%
2019-09-30	-19.01%
2019-06-30	-17.93%
2019-03-31	-14.35%
2018-12-31	-13.41%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-597.58%
2024-12-31	-235.16%
2023-12-31	-115.60%
2022-12-31	-87.80%
2021-12-31	-71.07%
2020-12-31	-32.78%
2019-12-31	-23.16%
2018-12-31	-13.41%
2017-12-31	-4.27%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BioCardia, Inc. (BCDA)	United States	$0.016B
Passage BIO, Inc. (PASG)	United States	$0.015B	-0.43
Pluri Inc. (PLUR)		$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)	United States	$0.013B	-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)	United States	$0.013B	-1.05
Jasper Therapeutics, Inc. (JSPR)	United States	$0.020B	-0.37
IN8BIO, INC. (INAB)	United States	$0.012B	-0.76
Estrella Immunopharma, Inc. (ESLA)	United States	$0.020B
Senti Biosciences Holdings, Inc. (SNTI)	United States	$0.011B	-0.70
TScan Therapeutics, Inc. (TCRX)	United States	$0.008B	-1.23